SN4
SHORT NOTE
5M
★ High-yield
Describe aplastic anaemia with its causes, features and investigations.
Definition
Aplastic anaemia is pancytopenia resulting from failure of the haemopoietic stem cells, with a hypocellular marrow replaced by fat and no abnormal infiltrate.
- Three features define it — pancytopenia, a hypocellular marrow, and the absence of infiltration, fibrosis or dysplasia
- Incidence is two to three times higher in Asia than in the West
Causes
| Category | Causes |
|---|---|
| Idiopathic — about 65% | Immune-mediated destruction of stem cells by cytotoxic T cells |
| Drugs | Chloramphenicol (idiosyncratic and dose-independent), phenylbutazone, gold, carbamazepine, phenytoin, sulphonamides, antithyroid drugs; cytotoxic chemotherapy (dose-dependent and predictable) |
| Chemicals | Benzene and other organic solvents; insecticides |
| Radiation | Whole-body irradiation; radiotherapy |
| Infection | Viral hepatitis (typically non-A, non-B, non-C), Epstein–Barr virus, HIV, parvovirus (pure red cell aplasia) |
| Inherited | Fanconi anaemia — autosomal recessive, with short stature, hyperpigmentation, thumb and radial anomalies, renal defects and chromosomal fragility; dyskeratosis congenita |
| Other | Paroxysmal nocturnal haemoglobinuria; pregnancy; thymoma |
Clinical Features
- The features follow directly from the three cell lines lost
- Anaemia — insidious pallor, fatigue, breathlessness
- Thrombocytopenia — petechiae, purpura, bleeding gums, epistaxis, menorrhagia; intracranial haemorrhage is a cause of death
- Neutropenia — recurrent infection, mouth ulcers, sore throat; infection is the commonest cause of death
- NO hepatosplenomegaly and NO lymphadenopathy — their presence argues strongly against the diagnosis and suggests leukaemia instead
CLINICAL PEARL
The absence of organomegaly is as diagnostic as the pancytopenia itself. Aplastic anaemia is a failure of production, so there is nothing to enlarge the spleen or nodes. Pancytopenia with hepatosplenomegaly points to leukaemia, lymphoma, hypersplenism, or in India to kala-azar — and the distinction is made at the bedside before the marrow is examined.
Investigations
- Full blood count — pancytopenia with a low reticulocyte count, which is the key: the marrow is not responding
- Peripheral smear — normocytic or macrocytic red cells; NO blasts and no abnormal cells
- Bone marrow aspirate and trephine biopsy is essential — aspiration often gives a "dry tap", so the trephine is required to show the hypocellular marrow replaced by fat
- Exclude the differentials — leukaemia, myelodysplasia, myeloma, megaloblastic anaemia, hypersplenism, kala-azar, HIV
- Flow cytometry for PNH and chromosomal fragility testing in the young
Applied Aspects
- Camitta criteria for severe disease — marrow cellularity under 25%, with any two of: neutrophils below 0.5, platelets below 20,000, reticulocytes below 20,000/mm3
- Allogeneic stem cell transplantation is curative and is the treatment of choice in the young with a matched sibling donor
- Immunosuppression with antithymocyte globulin and ciclosporin for older patients or those without a donor, reflecting the immune pathogenesis
- Supportive care determines survival in the short term — irradiated and leucodepleted blood products, prompt treatment of neutropenic fever, and avoidance of aspirin and intramuscular injections
- Avoid transfusion from family members if transplantation is a possibility, since it sensitises the recipient against the potential donor
- Chloramphenicol is still used in India and remains a preventable cause; its use should always prompt consideration of this diagnosis
All questions in Haematology I: Anaemias & Red-cell Disorders
- Q1Define anaemia. Classify anaemia morphologically and aetiologically. Describe the approach to its investigation. ★
- Q2Describe the causes, stages, laboratory findings and clinical features of iron deficiency anaemia. ★
- Q3Describe megaloblastic anaemia with its causes, laboratory findings and clinical features. Differentiate B12 from folate deficiency. ★
- Q4Classify haemolytic anaemias. Describe the laboratory findings and differentiate intravascular from extravascular haemolysis. ★
- Q5Describe the pathogenesis, clinical features and laboratory diagnosis of thalassaemia. ★
- SN1Describe sickle cell disease with its pathogenesis, crises and diagnosis. ★
- SN2Describe hereditary spherocytosis with its pathogenesis, features and diagnosis. ★
- SN3Describe G6PD deficiency with its pathogenesis, precipitating factors and diagnosis. ★
- SN4Describe aplastic anaemia with its causes, features and investigations. ★
- SN5Describe autoimmune haemolytic anaemia. Differentiate warm from cold types and explain the Coombs test. ★
- SN6Describe anaemia of chronic disease and differentiate it from iron deficiency anaemia. ★
- SN7Describe the abnormal red cell shapes and inclusions seen on a peripheral smear with their significance.